NZ205817A - Isolation of oxytetracycline-calcium-silicate-complex salt from fermentation broth - Google Patents
Isolation of oxytetracycline-calcium-silicate-complex salt from fermentation brothInfo
- Publication number
- NZ205817A NZ205817A NZ20581783A NZ20581783A NZ205817A NZ 205817 A NZ205817 A NZ 205817A NZ 20581783 A NZ20581783 A NZ 20581783A NZ 20581783 A NZ20581783 A NZ 20581783A NZ 205817 A NZ205817 A NZ 205817A
- Authority
- NZ
- New Zealand
- Prior art keywords
- water
- calcium
- silicate
- fermentation broth
- soluble
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims description 41
- 230000004151 fermentation Effects 0.000 title claims description 35
- 150000003839 salts Chemical class 0.000 title claims description 25
- 238000002955 isolation Methods 0.000 title description 4
- 238000000034 method Methods 0.000 claims description 29
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 24
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 235000019353 potassium silicate Nutrition 0.000 claims description 18
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 235000006408 oxalic acid Nutrition 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- 159000000007 calcium salts Chemical class 0.000 claims description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 229910001424 calcium ion Inorganic materials 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 230000020477 pH reduction Effects 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 39
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 34
- 239000000243 solution Substances 0.000 description 23
- 229910052742 iron Inorganic materials 0.000 description 20
- 239000000047 product Substances 0.000 description 13
- 239000013543 active substance Substances 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 239000000378 calcium silicate Substances 0.000 description 7
- 229910052918 calcium silicate Inorganic materials 0.000 description 7
- 229960003340 calcium silicate Drugs 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 239000010451 perlite Substances 0.000 description 4
- 235000019362 perlite Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 150000004760 silicates Chemical class 0.000 description 3
- QAQSNXHKHKONNS-UHFFFAOYSA-N 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide Chemical compound CCN1C(O)=C(C(N)=O)C(C)=CC1=O QAQSNXHKHKONNS-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- UETZVSHORCDDTH-UHFFFAOYSA-N iron(2+);hexacyanide Chemical compound [Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] UETZVSHORCDDTH-UHFFFAOYSA-N 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- -1 silicate ions Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- IMLJLCJZQLGHJS-JEKSYDDFSA-N (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;dihydrate Chemical compound O.O.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O IMLJLCJZQLGHJS-JEKSYDDFSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000896693 Disa Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000187419 Streptomyces rimosus Species 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- VANYVCHXDYVKSI-MXWBXKMOSA-L calcium;(6ar,10s,10ar,11s,11ar,12s)-8-carbamoyl-10-(dimethylamino)-4,6a,7,11,12-pentahydroxy-12-methyl-6,9-dioxo-10,10a,11,11a-tetrahydrotetracen-5-olate Chemical compound [Ca+2].C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C([O-])C2=C1O.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C([O-])C2=C1O VANYVCHXDYVKSI-MXWBXKMOSA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- VNWKDIUSXQCPGN-UHFFFAOYSA-J dicalcium tetrachloride Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Ca+2].[Ca+2] VNWKDIUSXQCPGN-UHFFFAOYSA-J 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002739 metals Chemical group 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 229960004548 oxytetracycline calcium Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- XWGJFPHUCFXLBL-UHFFFAOYSA-M rongalite Chemical compound [Na+].OCS([O-])=O XWGJFPHUCFXLBL-UHFFFAOYSA-M 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
-zos&i 7 7 . J L» „ i •.'($> y. •(.•■ii«i>»* •"**•••• Ccn-.plete Specification riled: Class: Publication Date: .. ^ MN.!???. P.O. Journal, No: J3>Q3 rt E A/ o>.
Patents Form No. 5 /rv I W MAY 1987 NEK ZEALAND PATENTS ACT 1953 COMPLETE SPECIFICATION "A PROCESS FOR IHE PREPARATION OF AN QXYTETRACYCLINE-CALCIUM SILICATE COMPLEX SALT FROM FERMENTATION BROTH" -I,WEBIOGAL GYOGYSZERGYAR, H-4042 Debrecen, Pallagi ut. 13., Hungary, a body corporate organised under the laws of Hungary, hereby declare the invention, for which -3-/we pray that a patent may be granted to-?oe-/us, and the method by which it is to be performed, to be particularly described in and by the following statement -1- (followed by page TA.) 205817 I* A P,IOCESS FOR THE PREPARATION OF AM OXYTETRACYCLINE-—CALCIUM SILICATE COMPLEX SALT FROM FERMEMTATIOM BROTH process to be performed in iron apparatus , too, for the preparation of an oxytetracycline-calciumsilicate complex salt from fermentation broth.
The oxytetracycline ( OTC ) is an antibiotic inhibiting the protein synthesis and the replication mechanism of numerous microorganisms which are used for the treatment of numerous diseases caused by pathogen microorganisms as well as owing to its weight-gain promoting and disease-preventing activity in agriculture as fodder additive. In large scale production OTC is produced by aerobic fernentat ion of St reptor.yces rinosus in a submerged culture followed by the isolation of the antibiotic from the raw fermentation broth and by the purification of the raw material. purification of the OTC are known. E.g. OTC may be extracted from an alkaline solution by butylalcohol (U.S. patent specification No. 2,516,030). Furthermore it may be attached to an ion exchange resin — ' : or precipitated by barium, calcium or magnesium ions (3. Am. Chen. Soc. TZ /1951/ 4211; British ihe invention relates to a simple, industrial Numerous processes for the isolation and A 2921-741/To 20581 patent specification No: 718,020), by quaternary ammonium salts (U.S. patent specification No: 2,873,276) or by arylazosulfonic acids (U.S. Patent specification No: 2,649,480). The cited processes have different disadvantages, e.g. the use of expensive apparatus, such as extractors, ion exchange columns or expensive chemicals (ion exchanger, quaternary ammonium salts, arylazosulfonic acids) or very toxic compounds (barium salts) .
It seems that the process according to Belgian Patent Specification No. 632331 can be carried out esentially simpler and easier: the OTC is precipitated in the presence of calcium ions by carbonate or hydrogen carbonate ions. However, the process proved to be hardly reproducable by us; the yield is not indicated in the cited publication.
A similar process which has been proposed presents a maximum yield of 55%. According to another proposal the OTC is precipitated onto the mycelium with a yield of 85%. Thus the pure active agent content of the product is naturally very low (about 13%). This fact is rather disadvantageous both for the preparation and the further purification since one has to work with very high volumes.
The large scale production, isolation and purification of the OTC is very difficult on account of 205817 the iron content of the fermentation broth. Iron gets into the fermentation broth with the components of the nutrient medium and from the wall of the iron fermenters and catalyzes the decomposition of the OTC as oxidizing agent, that is it reduces the quantity of the already synthesized active agent and spoils the yield of the purification steps (British patent specification No. 718,020). The Ci) iron content disa dvantageously influences the colour and the stability of the pure product , too-, it is known that the di- and trivalent metals form stable inner complexes with the OTC (D. Am. Chem. Soc. 73^ /1951/, 4211) which are not easyto decompose. One possibility to maintain the iron content of the fermentation broth on a ]_5 low level during the fermentation is the use of fermenters made of special steel. However, these apparatus are too expensive, for this reason fermentors made of iron are mostly used everywhere in the fermentation industry.
The iron concentration of the OTC containing 20 fermentation broth produced in iron fermenters is fairly high (about 30-60 gamma/ml, higher values are possible, too).
One tries to reduce the harmful effect of iron by converting it into soluble but not dissociating 25 complexes with different methods. The best known complexing agent for this purpose is the ethylene-diaminotet ra^a^e/t&c-- f 9 MAY 198?' 205817 -A - s.. -acid (EDTA) . Another possibility is to reduce the tri-valent iron e.g. by ascorbicacid, sodium-formaldehyde--sulfoxylate or sodium-dithionite to divalent iron because the divalent iron-OTC-complexes are fairly unstable and the divalent iron-ion does not catalyze the oxidation of the active agent. Finally, the iron can be precipitated e.g. by potassium-[hexacyanoferrate(II)] as insoluble iron (II, III)-[ hexacyanof e rrat e (II) ] (British patent specification No. 718,020). These processes have the disadvantage of using expensive reagents (EDTA, ascorbic acid) even in high quantities, but these cannot completely eliminate the harmful effect of iron. The reagent being most suitable for the precipitation of iron was potassium--[ hexacyanof errate(II)] , but using it in. the production means to have the possibility of forming hydrogen cyanide.
The aim of the invention was to elaborate a process by means of which OTC can be produced more economically, with a higher yield than before and if desired in a higher degree of purity with a simple technology and simple apparatus.
The invention is based in the recognation that OTC forms an insoluble, stable, easily filterable complex salt with water-soluble silicates in the presence of calcium ions.
Acoordingly the invention relates to a process for the preparation of an oxytetracycline-calciumsilicate--complex salt from the fermentation broth. According to 9Mtfw87i ceA 205817 the invention the fermentation broth (optionally.pre-treated with a surface-active substance) a) after an optional pretreatment with a water-soluble silicate, is acidified to a pH-value of 0.5 to 3.0, then the mycelium is filtered off - optionally using a filter aid, the pH-value of the filtrate is adjusted to 4-5 by a water-soluble lye and, after the addition of a calcium salt or in the presence of calcium ions, a water-soluble silicate and optionally a water-soluble carbonate or hydrogen carbonate is added, and after further stirring, the formed oxytretracycline-calciumsilicate-complex salt is filtered off, optionally in the presence of a filter aid, or b) is mixed with a calcium salt and a water-soluble silicate, if necessary the pH-value is adjusted to 8-11 by a water-soluble lye, optionally a water-soluble carbonate or hydrogen-carbonate is added to the mixture, and after further stirring, the oxytetracycline-calcium-silicate complex salt precipitated onto the mycelium is filtered off, optionally in the presence of a filter aid, and the oxytetracycline-calciumsilicate complex salt obtained according to paragraph a) or b) is dried at a temperature of 20 to 120°C.
According to variant a) the mycelium is filtered off after the acidification and the calciumsilicate complex is formed in the pure filtrate. According to process variant b) the complex is directly precipitated onto the 205817 mycelium. Variant b) consists of fewer steps, however, this product can be used only as a fodder additive. According to variant a) if desired an iron-free, very pure product can be obtained which can be further processed for pharmaceutical purposes.
The process is demonstrated in detail by means of a flow diagram.
Before the processing is started, the fermentation broth can optionally be pretreated with a surface-active substance. E.g. Sterogenole (cetylpyri-diniumbromide) is suitable. The surface-active substance essentially destroys the cell walls of the microorganism (Streptomyces rimosus) and thus sets free the intro-cellularly bound OTC, too.
This process called plasr.iolysis takes place at a pH-value of 5.3 to 5.6 and a temperature of about 40 °C while 0.001 to 0.03 % (related to the weight of the surface - active substance-of the fermentation broth)/is added until the complete dissolution of the cells. The fermentation broth treated with the above mentioned quantity of Sterogenole is free of cells under a microscope.
The plasmolysis is not necessary in every case. It is generally performed only if the fermentation broth is very thick and it is .difficult to stir it ,which' is particularly the case if during the fermentation fats and oils are added in order to prevent . foam >,.
I ' 9 MAV1987" i 205817 formation. In the case of such fermentation broth the yield of OTC may be highly increased by treating it with a surface-active substance because the quantity included in the cells, too, which otherwise would be lost, is affected, too.
According to process variant a) the fermentation broth is optionally pretreated by a water-soluble silicate. This step is carried out if an iron-free product shall be obtained. Related to its weight 0.1 to 3.0 %, preferably 1.5 to 2.0 % of a water-soluble silicate, suitably soda water-glass, are added to the fermentation broth. 3oth iron(II) and iron(III) are precipitated by the silicate ions in form of the silicates thereof, and they are insoluble in weak bases and weak acids. The precipitated iron silicates are later separated by the filtration process together with the mycelium .
The acidification of the fermentation broth to a pH-value of 0.5 to 3.0 preferably to 1.0 to 2.0, is 205S17 the following step. Organic and inorganic acids alike □ay be used for it. The use of phosphoric acid or acetic acid is not advisable because these acids catalyze the epinerisation of the OTC to the biologically ineffective 4-epimer. Hydrochloric acid attacks the active agent OTC too strongly. Oxalic acid and sulfuric acid proved to be the best ones. To use only oxalic acid is not economical. The best is to use their mixture, which consists of about 90 % of sulfuric acid and 10 % of oxalic acid. A mixture containing 11 per cent by weight of sulfuric acid and 1.5 per cent by weight of oxalic acid is used in a quantity of 30 to 120 ml, preferably 45 to 70 ml, related to 1 kg of the fermentation broth. Though in the course of the acidification a certain dfecomposition of the OTC takes place (0. An. Chem. Soc. 75 5455 /1953/), the losses can be kept under 6 % by chosing the conditions appropriately. tated, this too) is separated from the acidic fermentation broth by filtration. If necessary a filteraid, such as perlite, can be used. The mycelium on the filter is once washed out v/ith an acid of the said composition, the wash liquid is unified with the filtrate. In this way maximum 8 % of the total active agent remains in the mycelium. This quantity could be reached by further washing, too, but the liquid volumes would mean a problem Now the mycelium (if iron silicate is precipi- too big for further processing. 205817 - 9 " The OTC is precipitated from the acidic filtrate by calcium salt and a water-soluble silicate, preferably water-glass. If the iron was not precipitated in the first step and then removed, it precipitates now together with the complex salt and remains in this salt. There is a pH-value at which the iron(II) and iron(III) can be separated as silicates but the OTC is not damaged. A pH-value of 4 to 5 is optimal, this is adjusted by a basic substance, suitably by sodium hydroxide.
The rate by which the precipitation reagents are added influences the particle size of the precipitate. Generally a medium particle size is to be obtained since in the case of too snail particles the active agent again partly dissolves, and if they are too big, the precipitation is not complete.
As calcium salt calcium chloride is suitably used. As water-soluble silicate practically water glass to be obtained in trade (soda water glass = sodium silicate) is at disposal. It is suitably diluted with water to a fourfold of its volume. 1 to 20 nl, preferably 4 to 9 ml original of this dilution related to 1 kg/fermentation broth are necessary.
To make the precipitation complete, the pH--value is adjusted to 8 to 11 with 2 fi/ sodium hydroxide solution. The mixture is stirred for 30 minutes to 5 hours. The precipitation takes place more rapidly still if';a; E ; \ carbonate or .hydrogen-carbonate is added. This zs>; probably r'9MAVI98| \ -C 205817 a salting out effect. Sodium hydrogen-carbonate which is suitably used in a 10 per cent solution is the most original suitable one. For 1 kg of/fermentation broth one takes the sodium 0.5 to 10 g, preferably 1 to 3 g of/hydrogen-carbonate.
Then the precipitated complex is separated from the mother liquor as soon as possible so that the active agent does not dissolve. The correct time is determined by measuring the OTC concentration of the mother liquor, if it has attained a minimum value, filtration is performed. A filter -aid may optionally be used. Under these conditions maximum 0.04 to 0.06 mg/ml of OTC remain in the mother liquor, that is the loss caused by the OTC remaining in the mother liquor is less than 1 %.
Then the filter-wet OTC complex salt is dried under atmospheric pressure or in vacuo. The drying temperature is between 20 and 120 °C, preferably 100 and 110 °C. By constant stirring, separating and turning the drying time is kept as short as possible since the alkaline substance contained in the complex salt (Na, Ca compounds) could attack the active agent.
According to process variant b) the fermentation broth is directly reacted with the precipitation reagents, thatis the calcium salt and the water-soluble silicate.
The water-soluble silicate (soda water-glass) is diluted by volume with water in a ratio of l:l/in this case and used in a quantity of 5-100 ml, preferably 15 to 25 ml, related^ to 1 kg of fermentation broth.
IN 1SJUN1987' 2 0 5 8 1 Water-glass is strongly basic. If the pH-value of 8-11 optimal for the precipitation should not be attained yet, it is adjusted alkaline by adding a water--soluble base. A carbonate or hydrogen-carbonate may be added for the promotion of the precipitation process. The quantity and the form of the added substance are identical with those given in paragraph a) . The complex salt directly precipitated on the mycelium is separated and dried as described in paragraph a).
According to the process of the invention an 0TC-calcium-silicate complex salt can be prepared in iron fermenters, too, the total iron content mobilizable by diluted acids of which is 2-200 gamma/g. This product is suitable for the preparation of OTC-hydrochloride and OTC-dihydrate. A further advantage of the process according the invention resides in the fact that the yield is higher than with the known processes: about 85 % of the OTC contained in the fermentation broth can be obtained. The obtained complex salt contains about 50 % of an active agent according to variant a) and about 18-20 % according to variant b). The product obtained according to variant b) may be used directly for fodder purposes.
The invention is demonstrated more in detail by means of the following working examples.
Example 1 To 2132 g of OTC-fermentation broth (containing totally 15.56 g of OTC) 40 ml of soda water-glass diluted X 2058(7 in a ratio of 1:1 (soda water-glass comprising an Na20 content of 12-13 weight percent, i.e. an Na20/Si O2 ratio of 1/2.6 - 1/2.7 respectively, and water in a ratio of 1:1) are added under stirring at room temperature. Then 150 q1 of a 10 per cent calcium chloride solution are added and the pH-value is adjusted to 9 by soda water- by volume -glass diluted in a ratio of l:l/of which about 200 ml are necessary. The mixture is stirred for 2 hours, then filtered off. 157.8 g of a dry product are obtained, it contains 14.517 g (9.2 %) of pure active agent, this yield corresponds to 93 % related to the initial activity. Example 2 45 ml of soda water-glass diluted in a ratio by volume of l:l/and then 86 ml of 10 per cent CaC^ solution are added to 2076 g of OTC-fermentation broth (containing 16.320 g of OTC) at room temperature. Then the pH-value is adjusted to 9.2 by 2 |j sodium hydroxide solution and the mixture is reacted with 75 ml of 10 per cent sodium hydrogen carbonate solution. The mixture is stirred for 2 hours and filtrated after adding 11 g of perlite. The weight of the dry product is 83.0 g and it contains 15.520 g (18.7 %) of OTC what corresponds to a yield of 95 %.
Example 3 50 ml of soda water-glass diluted in a ratio by volume of l:l/are added to 2042 g of OTC-f e rment a t ion broth (containing totally 19.68 g of OTC) under stirring at room temperature. Then the pH-value is adjusted to 1 by 25 per 205817 cent sulfuric acid of which about 200 ml are used. The mixture is stirred for 30 minutes, after adding 6 g of perlite, filtrated and the mycelium is washed on the filter with 800 cnl of water. Filtrate and wash water are unified. The obtained 2700 ml of liquid contain 17.52 g of OTC. The pH-value is adjusted to 4.5 by 2N sodium hydroxide solution under stirring. The precipitation reagents: 160 ml of 10 per cent calcium chloride solution and soda water-glass diluted in a ratio of 1:3 are added.
Soda water-glass is used till the pH-value rises to 6.5 (about 29 ml). Then the pH-value is adjusted to 9.2 by 2sodium hydroxide solution and 50 ml of 10 per cent sodium hydrogen carbonate solution are added. 3 hours later filtration and drying are performed. 39.78 g of the product are obtained which contains totally 14.96 g of OTC what corresponds to a yield of 76 %.
Example 4 153 ml of 10 per cent oxalic acid (=90 ml/kg) are added to 1704 g of OTC-fermentation broth (containing totally 16.040 g of OTC) under stirring at room temperature. The pH-value drops to 2. The mixture is filtrated and the mycelium is washed with 426 ml of water (= 250 ml/kg). Filtrate and wash water are unified. The obtained 1970 ml of liquid contains 13.794 g of OTC. The pH-value of solution is adjusted to 4.5 by 2 fy sodium hydroxide soiu- ^ V tion. Then 52 ml of 10 per cent CaCl2 solution and Y1987^ o until a pH-value of 6.5 water glass diluted in a ratio of 1:3 with water (about 21 ml) are added. After one hour of stirring the pH-value is adjusted to 9 by 2tJ sodium hydroxide solution. Stirring is continued for three hours, the product is filtrated off and dried. 28.29 g of the product are obtained which contains 13.040 g (46.1 %) of OTC, what corresponds to a yield of 81 %.
Example 5 127 ml of a sulfuric acid/oxalic acid mixture containing 11 per cent by weight of sulfuric acid and 1.5 per cent by weight of oxalic acid are added to 2124 g of OTC-fermentation broth (containing totally 18.035 g-OTC) at room temperature. The pH-value drops to 2. The mixture is stirred for one hour, then perlite is added in a quantity of 5 g/kg and the mixture is filtered. The mycelium is washed by 530 ml of water. The 2390 ml of liquid obtained by unifying the filtrate and the wash water contain 16.646 g of OTC. The pH-value of the solution is adjusted to 4.5 by 2N sodium hydroxide solution. 52.4 ml of water glass diluted in a ratio of 1:3 by water and 160 ml of 10 per cent CaClg-solution are added to the solution. The pH-value amounting to about 6.5 after this step is adjusted to 9.2 by 2\{ sodium hydroxide solution. 51 ml of 10 per cent sodium hydrogen carbonate solution are added to the solution. After 2 hours filtration and drying are carried out. 43.69 g of a complex salt containing totally 16.033 g of * 205817 -~r OTC are obtained. The OTC-yield is 89 %.
Example 6 From 2109 g of OTC-fermentation broth (containing totally 20.035 g OTC) 2373 ml of filtrate (containing 5 18.432 g of OTC) are prepared as described in Example 5.
The pH-value of the filtrate is adjusted to 4.5 by sodium hydroxide solution (about 88 ml), then after adding 180 ml of 10 per cent CaC^-solut ion the pH-value is at first adjusted to 6.5 by water-glass diluted in a ratio 10 of 1:3 (about 35 ml are necessary), then to 9.2 by 2 N sodium hydroxide solution (about 79 ml). A volume of 10 per cent sodium hydrogen carbonate solution (about 35 ml) corresponding to the added volume of water glass is added. After two hours of stirring filtration is performed. The 15 product is dried by hot air (100-110 °C). 43.6 g of a complex salt are obtained which contains totally 17.43 g of OTC what corresponds to a yield of 87 %.
Example 7 0.63 g of Sterogenole (cetylpyridiniumbromide) 20 in form of a 10 per cent solution prepared with warm water is added to 2065 g of OTC-fermentation broth (containing totally 21.578 g of OTC) under stirring. The pH-value of the mixture is adjusted to 5.3 - 5.6 by the acid mixture used in Example 5, too. The mixture is heated 25 to 40 °C within 30 minutes and stirred at this temperature for 2 hours. After cooling to room temperature the 'v ^ /. treated fermentation broth may be further processed^' \ *9 MAY 1987* 2058 according to any of Examples 3 to 6. Depending on the desired purity degree yields of 80 to 90 % are obtained 205817
Claims (8)
1. A process for the preparation of an oxytetracycline-calcium-silicate-complex salt from a fermentation broth, characterized in that the fermentation broth (optionally pretreated with a surface-active substance) a) after an optional pretreatment by a water-soluble silicate, is acidified to a pH-value of 0.5 - 3.0, then the mycelium is filtered off - optionally using a filter aid, the pH-value of the filtrate is adjusted to 4-5 by a water-soluble lye and, after the addition of a calcium salt or in the presence of calcium ions, a water-soluble silicate and optionally a water-soluble carbonate or hydrogen-carbonate is added, and after further stirring the formed oxytetracycline-calcium-silicate-complex salt is filtered off, optionally in the presence of a filter aid, or b) is admixed with a calcium salt and a water-soluble silicate, if necessary the pH-value is adjusted to 8 to 11 by a water-soluble lye, optionally a water-soluble carbonate or hydrogen-carbonate is added to the mixture, and after further stirring the oxytetracycline-calcium-silicate-complex salt precipitated onto the mycelium is filtered off, optionally in the presence of a filter aid, and the oxytetracycline-calcium-silicate-complex salt obtained according to paragraph a) or b) is dried at a temperature of 20 to 120°C. ;;'v ;19MAY|9(J7 - 18 - 205817
2. A process as claimed in claim la), characterized in that a mixture of oxalic acid and sulfuric acid is used for the acidification to a pH-value of 0.5 to 3.0.
3. A process as claimed in claim la), characterized in that,for the oxytetracycline-calcium-silicate-complex salt formation,soda water glass obtainable in the trade and diluted in a ratio of 1;3 by volume by water is used as the water-soluble silicate in a quantity of 1-20 ml, related to 1 kg of original fermentation broth.
4. A process as claimed in claim lb) characterized in that soda water glass diluted in a ratio of 1:1 by volume by water is used as the water-soluble silicate in a quantity of 5-100 ml, related to 1 kg of fermentation broth.
5. A process as claimed in claim 1, characterized in that calcium chloride is used as the calcium salt.
6. A process as claimed in claim 1, characterized in that sodium hydrogen-carbonate is used as the water-soluble hydrogen-carbonate.
7. A process for the preparation of an oxytetracycline-calcium-silicate-complex salt from a fermentation broth, substantially as herein particularly described with reference to any one of the Examples.
8. A process for the preparation of an oxytetracycline-calcium-silicate-complex salt from a fermentation broth. herein-described with reference to the ? BIOC )
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ20581783A NZ205817A (en) | 1983-09-29 | 1983-09-29 | Isolation of oxytetracycline-calcium-silicate-complex salt from fermentation broth |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ20581783A NZ205817A (en) | 1983-09-29 | 1983-09-29 | Isolation of oxytetracycline-calcium-silicate-complex salt from fermentation broth |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ205817A true NZ205817A (en) | 1988-01-08 |
Family
ID=19920526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ20581783A NZ205817A (en) | 1983-09-29 | 1983-09-29 | Isolation of oxytetracycline-calcium-silicate-complex salt from fermentation broth |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ205817A (en) |
-
1983
- 1983-09-29 NZ NZ20581783A patent/NZ205817A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3801499A (en) | Sewage treatment | |
US3714063A (en) | Method and composition for emulsifying petroleum products with a viewto preparing a culture medium for microorganisms | |
CN105967436A (en) | Method for biodegradation of organic phosphorus pesticide wastewater | |
US20020098553A1 (en) | Process for producing carrageenan with reduced amount of insoluble material | |
CN105130014A (en) | Preparation method and application of cation-modified glycoprotein type microorganism flocculating agent | |
US4584135A (en) | Process for the preparation of an oxytetracycline-calcium silicate complex salt from fermentation broth | |
CN112301006B (en) | Method for accelerating filtration speed of pichia pastoris fermentation broth | |
NZ205817A (en) | Isolation of oxytetracycline-calcium-silicate-complex salt from fermentation broth | |
CN110256516A (en) | A kind of preparation method of poly IC | |
CN110724211B (en) | High-value comprehensive utilization method of shrimp and crab shells based on reducing sugar catalytic oxidation and application thereof | |
US3957579A (en) | Method for preparing d-tartaric acid | |
US3661715A (en) | Process for the preparation of proteases active in alkaline medium | |
FI66414C (en) | FOERFARANDE FOER FRAMSTAELLNING AV LIGNOSULFONATBASERADE BLANDNINGAR FOER ANVAENDNING I SYNNERHET SAOSOM TILLSATSAEMNEN FOR BETONG | |
RU2312073C1 (en) | Process for biosorption purification of effluents to remove heavy metal ions | |
JPS5626194A (en) | Purification of long-chain dicarboxylic acid produced by fermentation | |
SU452103A3 (en) | The method of obtaining -dihydroxy-3-4-phenylalanine | |
SU798164A1 (en) | Method of melasses preparation for fermentation in citric acid production | |
CN116809593A (en) | Low-cost dealkalization method for red mud | |
CS272748B1 (en) | Method of d-mannose and d-arabinose | |
SU901270A1 (en) | Method of processing fur scrap | |
JPH0833493A (en) | Production of l-aspartic acid | |
JPH06128067A (en) | Production of phosphatic fertilizer and equipment therefor | |
CN112624914A (en) | Preparation method of calcium gluconate | |
JPH0775561A (en) | Microbial flocculant production medium and production method | |
GB315877A (en) | Method of purification of solutions of enzymes for use in various industries and the like |